» Articles » PMID: 31049571

MicroRNA-221 and MicroRNA-222 in Common Human Cancers: Expression, Function, and Triggering of Tumor Progression As a Key Modulator

Overview
Journal Lab Med
Date 2019 May 4
PMID 31049571
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are a class of short (~22 nucleotides [nt]), single-stranded RNA oligonucleotides that are regulatory in nature and are often dysregulated in various diseases, including cancer. miRNAs can act as oncomiRs (miRNAs associated with cancer) or tumor suppressor miRNAs and have the potential to be a diagnostic, prognostic, noninvasive biomarker for these diseases. MicroRNA-221 (miR-221) and microRNA-222 (miR-222) are homologous miRNAs, located on the human chromosome Xp11.3, which factored significantly in impairment in the regulation of a wide range of cancers. In this review, we have highlighted the most consistently reported dysregulated miRNAs that trigger human tissues to express cancerous features and surveyed the role of those miRNAs in metastasis, apoptosis, angiogenesis, and tumor prognosis. Also, we applied the causes of drug resistance and the role of coordinated actions of these miRNAs to epigenetic changes and selected miRNAs as a potential type of cancer treatment.

Citing Articles

The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells.

Abolhasani S, Ahmadi Y, Rostami Y, Fattahi D Cell Div. 2025; 20(1):6.

PMID: 40055797 PMC: 11887104. DOI: 10.1186/s13008-025-00146-0.


Investigating miR-9 and miR-222 in CSF and Plasma of Neuroblastoma Patients as Metastatic and Apoptotic-Related Markers.

Bordbar F, Rigi A, Mastanabad M, Rohani F, Ghaedi E, Dhiaa S Cell Biochem Biophys. 2024; .

PMID: 39663279 DOI: 10.1007/s12013-024-01570-9.


Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs.

Hassanin A, Ramos K Int J Mol Sci. 2024; 25(19).

PMID: 39409003 PMC: 11477113. DOI: 10.3390/ijms251910674.


Therapeutic Strategies for Angiogenesis Based on Endothelial Cell Epigenetics.

Cai Y, Li L, Shao C, Chen Y, Wang Z J Cardiovasc Transl Res. 2024; 17(4):816-827.

PMID: 38294628 DOI: 10.1007/s12265-024-10485-y.


MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.

Kim J, Jung E, Kim J, Son Y, Lee H, Kwag S Exp Ther Med. 2023; 25(3):127.

PMID: 36845963 PMC: 9947582. DOI: 10.3892/etm.2023.11826.